NeoGenomics Announces Chief Executive Officer Succession
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Raymond James Reiterates Market Perform Rating on Neogenomics (NEO) 'in light of the moving parts'
January 10, 2025 1:00 PM ESTRaymond James analyst Andrew Cooper reiterated a Market Perform rating and {REMOVEPT} price target on Neogenomics (NASDAQ: NEO)
The analyst comments "This morning, NeoGenomics announced the retirement of current CEO Chris Smith, naming board member Tony Zook as his successor effective the start of 2Q. The company also reaffirmed its 2024 guidance as part of the release. The retirement is somewhat of a surprise, but comes after a near double move since announcement of Smiths appointment and nearly... More
